GSDMB参与恶性肿瘤的研究进展
Research Progress of GSDMB Involved in Malignant Tumors
DOI: 10.12677/acm.2024.1482321, PDF,   
作者: 白 瑞*, 岳根全#：内蒙古医科大学第一临床医学院，内蒙古 呼和浩特
关键词: GSDMB；焦亡；恶性肿瘤；癌症；GSDMB； Pyroptosis； Malignant Tumor； Cancer
摘要: 细胞焦亡是一种炎症性程序性死亡方式，是一种有别于传统的坏死、凋亡等的新型细胞死亡方式，主要由成孔蛋白Gasdermin (GSDM)家族介导。活化的半胱氨酸天冬氨酸特异性蛋白酶(caspase)切割Gasdermin家族成员释放N端结构域在胞膜上打孔，从而导致细胞肿胀破裂死亡。Gasdermin B (GSDMB)属于Gasdermin (GSDM)家族，具有促肿瘤或抗肿瘤作用。在肿瘤细胞的相关研究中发现，GSDMB在乳腺癌、胃癌、肝癌、宫颈癌和结肠癌等癌细胞中高表达。因此，学者们认为GSDMB可能作为癌基因参与了癌症的进展和转移。本文综述了GSDMB在各种恶性肿瘤中的作用，以期为肿瘤的临床诊断、治疗及预后提供新的思路。
Abstract: Pyroptosis is an inflammatory programmed cell death, which is different from traditional necrosis and apoptosis. It is mainly mediated by the poreforming protein Gasdermin (GSDM) family. Activated caspases cleave Gasdermin family members to release N-terminal domains that punch holes in the cell membrane, leading to cell swelling, rupture and death. Gasdermin B (GSDMB) belongs to the Gasdermin (GSDM) family and has pro-or anti-tumor effects. Studies on tumor cells have found that GSDMB is highly expressed in breast cancer, gastric cancer, liver cancer, cervical cancer and colon cancer cells. Therefore, scholars believe that GSDMB may be involved in cancer progression and metastasis as an oncogene. This article reviews the role of GSDMB in various malignant tumors, in order to provide new ideas for the clinical diagnosis, treatment and prognosis of tumors.
文章引用：白瑞, 岳根全. GSDMB参与恶性肿瘤的研究进展[J]. 临床医学进展, 2024, 14(8): 1063-1072. https://doi.org/10.12677/acm.2024.1482321

参考文献

[1] Bray, F., Jemal, A., Grey, N., Ferlay, J. and Forman, D. (2012) Global Cancer Transitions According to the Human Development Index (2008-2030): A Population-Based Study. The Lancet Oncology, 13, 790-801. [Google Scholar] [CrossRef] [PubMed]
[2] Cai, Z. and Liu, Q. (2019) Understanding the Global Cancer Statistics 2018: Implications for Cancer Control. Science China Life Sciences, 64, 1017-1020. [Google Scholar] [CrossRef] [PubMed]
[3] Feng, R., Zong, Y., Cao, S. and Xu, R. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statistics? Cancer Communications, 39, 1-12. [Google Scholar] [CrossRef] [PubMed]
[4] Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., et al. (2018) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. [Google Scholar] [CrossRef] [PubMed]
[5] Wu, C., Li, M., Meng, H., Liu, Y., Niu, W., Zhou, Y., et al. (2019) Analysis of Status and Countermeasures of Cancer Incidence and Mortality in China. Science China Life Sciences, 62, 640-647. [Google Scholar] [CrossRef] [PubMed]
[6] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[7] Shi, J., Gao, W. and Shao, F. (2017) Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. Trends in Biochemical Sciences, 42, 245-254. [Google Scholar] [CrossRef] [PubMed]
[8] Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., et al. (2020) Pyroptosis: A New Frontier in Cancer. Biomedicine & Pharmacotherapy, 121, Article ID: 109595. [Google Scholar] [CrossRef] [PubMed]
[9] 李丽莎 ,李燕京, 白玉贤. Gasdermin家族调控肿瘤细胞焦亡的研究进展[J]. 中国肿瘤, 2020, 29(4): 285-291.
[10] Oltra, S.S., Colomo, S., Sin, L., Pérez-López, M., Lázaro, S., Molina-Crespo, A., et al. (2023) Distinct GSDMB Protein Isoforms and Protease Cleavage Processes Differentially Control Pyroptotic Cell Death and Mitochondrial Damage in Cancer Cells. Cell Death & Differentiation, 30, 1366-1381. [Google Scholar] [CrossRef] [PubMed]
[11] Lutkowska, A., Roszak, A., Lianeri, M., Sowińska, A., Sotiri, E. and Jagodziński, P.P. (2017) Analysis of Rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and Its Impact on Gasdermin B Expression. Molecular Diagnosis & Therapy, 21, 199-207. [Google Scholar] [CrossRef] [PubMed]
[12] Li, L., Li, Y. and Bai, Y. (2020) Role of GSDMB in Pyroptosis and Cancer. Cancer Management and Research, 12, 3033-3043. [Google Scholar] [CrossRef] [PubMed]
[13] Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. (2015) Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death. Nature, 526, 660-665. [Google Scholar] [CrossRef] [PubMed]
[14] Das, S., Miller, M. and Broide, D.H. (2017) Chromosome 17q21 Genes ORMDL3 and GSDMB in Asthma and Immune Diseases. Advances in Immunology, 135, 1-52. [Google Scholar] [CrossRef] [PubMed]
[15] Feng, S., Fox, D. and Man, S.M. (2018) Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death. Journal of Molecular Biology, 430, 3068-3080. [Google Scholar] [CrossRef] [PubMed]
[16] Chao, K.L., Kulakova, L. and Herzberg, O. (2017) Gene Polymorphism Linked to Increased Asthma and IBD Risk Alters Gasdermin-B Structure, a Sulfatide and Phosphoinositide Binding Protein. Proceedings of the National Academy of Sciences of the United States of America, 114, E1128-E1137. [Google Scholar] [CrossRef] [PubMed]
[17] Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., et al. (2016) Pore-forming Activity and Structural Autoinhibition of the Gasdermin Family. Nature, 535, 111-116. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, Z., He, H., Wang, K., Shi, X., Wang, Y., Su, Y., et al. (2020) Granzyme a from Cytotoxic Lymphocytes Cleaves GSDMB to Trigger Pyroptosis in Target Cells. Science, 368, eaaz7548. [Google Scholar] [CrossRef] [PubMed]
[19] Panganiban, R.A., Sun, M., Dahlin, A., Park, H., Kan, M., Himes, B.E., et al. (2018) A Functional Splice Variant Associated with Decreased Asthma Risk Abolishes the Ability of Gasdermin B to Induce Epithelial Cell Pyroptosis. Journal of Allergy and Clinical Immunology, 142, 1469-1478.E2. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, Q., Shi, P., Wang, Y., Zou, D., Wu, X., Wang, D., et al. (2018) GSDMB Promotes Non-Canonical Pyroptosis by Enhancing Caspase-4 Activity. Journal of Molecular Cell Biology, 11, 496-508. [Google Scholar] [CrossRef] [PubMed]
[21] de Vasconcelos, N.M., Van Opdenbosch, N., Van Gorp, H., Parthoens, E. and Lamkanfi, M. (2018) Single-Cell Analysis of Pyroptosis Dynamics Reveals Conserved GSDMD-Mediated Subcellular Events That Precede Plasma Membrane Rupture. Cell Death & Differentiation, 26, 146-161. [Google Scholar] [CrossRef] [PubMed]
[22] Hergueta-Redondo, M., Sarrio, D., Molina-Crespo, Á., Vicario, R., Bernadó-Morales, C., et al. (2016) Gasdermin B Expression Predicts Poor Clinical Outcome in HER2-Positive Breast Cancer. Oncotarget, 7, 56295-56308. [Google Scholar] [CrossRef] [PubMed]
[23] Molina-Crespo, Á., Cadete, A., Sarrio, D., Gámez-Chiachio, M., Martinez, L., Chao, K., et al. (2019) Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness. Clinical Cancer Research, 25, 4846-4858. [Google Scholar] [CrossRef] [PubMed]
[24] Hergueta-Redondo, M., Sarrió, D., Molina-Crespo, Á., Megias, D., Mota, A., Rojo-Sebastian, A., et al. (2014) Gasdermin-B Promotes Invasion and Metastasis in Breast Cancer Cells. PLOS ONE, 9, e90099. [Google Scholar] [CrossRef] [PubMed]
[25] Gámez-Chiachio, M., Molina-Crespo, Á., Ramos-Nebot, C., Martinez-Val, J., Martinez, L., Gassner, K., et al. (2022) Gasdermin B Over-Expression Modulates HER2-Targeted Therapy Resistance by Inducing Protective Autophagy through Rab7 Activation. Journal of Experimental & Clinical Cancer Research, 41, Article No. 285. [Google Scholar] [CrossRef] [PubMed]
[26] Forouzanfar, M.H., Foreman, K.J., Delossantos, A.M., Lozano, R., Lopez, A.D., Murray, C.J.L., et al. (2011) Breast and Cervical Cancer in 187 Countries between 1980 and 2010: A Systematic Analysis. The Lancet, 378, 1461-1484. [Google Scholar] [CrossRef] [PubMed]
[27] Sun, Q., Yang, J., Xing, G., Sun, Q., Zhang, L. and He, F. (2008) Expression of GSDML Associates with Tumor Progression in Uterine Cervix Cancer. Translational Oncology, 1, 73-83, IN1. [Google Scholar] [CrossRef] [PubMed]
[28] Li, S., Li, X., Zhang, S., Feng, Y., Jia, T., Zhu, M., et al. (2022) Association between GSDMB Gene Polymorphism and Cervical Cancer in the Northeast Chinese Han Population. Frontiers in Genetics, 13, Article 860727. [Google Scholar] [CrossRef] [PubMed]
[29] Lenis, A.T., Lec, P.M., Chamie, K. and Mshs, M. (2020) Bladder Cancer. JAMA, 324, 1980-1991. [Google Scholar] [CrossRef] [PubMed]
[30] Gu, L., Chen, Y., Li, X., Mei, Y., Zhou, J., Ma, J., et al. (2022) Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer. Cancers, 14, Article 3739. [Google Scholar] [CrossRef] [PubMed]
[31] He, H., Yi, L., Zhang, B., Yan, B., Xiao, M., Ren, J., et al. (2021) USP24-GSDMB Complex Promotes Bladder Cancer Proliferation via Activation of the STAT3 Pathway. International Journal of Biological Sciences, 17, 2417-2429. [Google Scholar] [CrossRef] [PubMed]
[32] Wang, C., Cao, Q., Zhang, S., Liu, H., Duan, H., Xia, W., et al. (2023) Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line. Pharmacogenomics and Personalized Medicine, 16, 219-228. [Google Scholar] [CrossRef] [PubMed]
[33] Jonasch, E., Gao, J. and Rathmell, W.K. (2014) Renal Cell Carcinoma. BMJ, 349, g4797. [Google Scholar] [CrossRef] [PubMed]
[34] Jonasch, E., Walker, C.L. and Rathmell, W.K. (2020) Clear Cell Renal Cell Carcinoma Ontogeny and Mechanisms of Lethality. Nature Reviews Nephrology, 17, 245-261. [Google Scholar] [CrossRef] [PubMed]
[35] Ma, J., Kang, Z., Yang, G., Wang, X., Si, M., Wang, Y., et al. (2023) Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy. Frontiers in Bioscience-Landmark, 28, Article 334. [Google Scholar] [CrossRef] [PubMed]
[36] Fu, L., Bao, J., Li, J., Li, Q., Lin, H., Zhou, Y., et al. (2022) Crosstalk of Necroptosis and Pyroptosis Defines Tumor Microenvironment Characterization and Predicts Prognosis in Clear Cell Renal Carcinoma. Frontiers in Immunology, 13, Article 1021935. [Google Scholar] [CrossRef] [PubMed]
[37] Cui, Y., Zhou, Z., Chai, Y. and Zhang, Y. (2021) Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Journal of Immunology Research, 2021, Article ID: 7753553. [Google Scholar] [CrossRef] [PubMed]
[38] Brenner, H., Rothenbacher, D. and Arndt, V. (2009) Epidemiology of Stomach Cancer. In: Verma, M., Ed., Methods in Molecular Biology, Humana Press, 467-477. [Google Scholar] [CrossRef] [PubMed]
[39] Lin, W., Zhang, Y., Yang, Y., Lin, B., Zhu, M., Xu, J., et al. (2023) Anti‐Pd‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis. Advanced Science, 10, Article ID: 2303908. [Google Scholar] [CrossRef] [PubMed]
[40] Saeki, N., Komatsuzaki, R., Chiwaki, F., Yanagihara, K. and Sasaki, H. (2015) A GSDMB Enhancer-Driven HSV Thymidine Kinase-Expressing Vector for Controlling Occult Peritoneal Dissemination of Gastric Cancer Cells. BMC Cancer, 15, Article No. 439. [Google Scholar] [CrossRef] [PubMed]
[41] Komiyama, H., Aoki, A., Tanaka, S., Maekawa, H., Kato, Y., Wada, R., et al. (2010) Alu-Derived Cis-Element Regulates Tumorigenesis-Dependent Gastric Expression of GASDERMIN B (GSDMB). Genes & Genetic Systems, 85, 75-83. [Google Scholar] [CrossRef] [PubMed]
[42] Ren, C., Li, J., Zhou, Y., Zhang, S. and Wang, Q. (2022) Typical Tumor Immune Microenvironment Status Determine Prognosis in Lung Adenocarcinoma. Translational Oncology, 18, Article ID: 101367. [Google Scholar] [CrossRef] [PubMed]
[43] Cui, J., He, Y., Zhu, F., Gong, W., Zuo, R., Wang, Y., et al. (2023) Inetetamab, a Novel Anti-Her2 Monoclonal Antibody, Exhibits Potent Synergistic Anticancer Effects with Cisplatin by Inducing Pyroptosis in Lung Adenocarcinoma. International Journal of Biological Sciences, 19, 4061-4081. [Google Scholar] [CrossRef] [PubMed]
[44] Bousali, M., Papatheodoridis, G., Paraskevis, D. and Karamitros, T. (2021) Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms, 9, Article 1787. [Google Scholar] [CrossRef] [PubMed]
[45] Ioannou, G.N. (2021) Epidemiology and Risk-Stratification of NAFLD-Associated HCC. Journal of Hepatology, 75, 1476-1484. [Google Scholar] [CrossRef] [PubMed]
[46] Hu, K., Xu, Z., Yao, L., Yan, Y., Zhou, L. and Li, J. (2021) Integrated Analysis of Expression, Prognostic Value and Immune Infiltration of GSDMs in Hepatocellular Carcinoma. Aging, 13, 24117-24135. [Google Scholar] [CrossRef] [PubMed]
[47] Wei, C., Zhou, J., Tao, W., Qin, L., Zhang, K., Huang, J., et al. (2024) Assessment the Value of Pyroptosis-Associated Gasdermin Family Genes in Hepatocellular Carcinoma: A Multi-Omics Comprehensive Analysis. Journal of Cancer, 15, 1966-1982. [Google Scholar] [CrossRef] [PubMed]
[48] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[49] Sun, L., Wang, J., Li, Y., Kang, Y., Jiang, Y., Zhang, J., et al. (2024) Correlation of Gasdermin B Staining Patterns with Prognosis, Progression, and Immune Response in Colorectal Cancer. BMC Cancer, 24, Article No. 567. [Google Scholar] [CrossRef] [PubMed]
[50] Pittaway, J.F.H. and Guasti, L. (2019) Pathobiology and Genetics of Adrenocortical Carcinoma. Journal of Molecular Endocrinology, 62, R105-R119. [Google Scholar] [CrossRef] [PubMed]
[51] Gao, J., Wang, D., Yang, Q., Tang, M., Du, J., He, L., et al. (2023) The Signature of Pyroptosis-Related Gene Prognostic and Immune Microenvironment in Adrenocortical Carcinoma. Frontiers in Molecular Biosciences, 10, Article 1131402. [Google Scholar] [CrossRef] [PubMed]
[52] Lecocq, Q., Keyaerts, M., Devoogdt, N. and Breckpot, K. (2020) The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time’s a Charm. International Journal of Molecular Sciences, 22, Article 75. [Google Scholar] [CrossRef] [PubMed]

为你推荐